CSL - Operating Expenses

Stock Price
141.15
Daily Change
0.49 0.35%
Monthly
-7.59%
Yearly
-43.01%
Q1 Forecast
138.07

CSL reported $5.7B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Arca Biopharma USD 25.09M 5.23M Mar/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
Bio Path USD 3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD 3.09M 100K Mar/2025
Cara Therapeutics USD 4.96M 2.38M Mar/2025
CSL USD 5.7B 2.82B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Esperion Therapeutics USD 83.21M 14.06M Dec/2025
Immunic USD 25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD 10.7M 1.54M Jun/2023
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
TherapeuticsMD USD 1.41M 50K Jun/2024